Description
BSE announces listing of 91,86,490 equity shares of Suven Life Sciences Ltd issued through preferential allotment with warrant conversion, effective August 28, 2025.
Summary
BSE has announced the listing and trading permission for 91,86,490 new equity shares of Suven Life Sciences Ltd (Scrip Code: 530239) effective from Thursday, August 28, 2025. These shares were issued at a premium through preferential allotment pursuant to warrant conversion.
Key Points
- 91,86,490 equity shares of Rs. 1/- each issued at premium of Rs. 133/-
- Issued to Non Promoters on preferential basis through warrant conversion
- Shares rank pari-passu with existing equity shares
- Distribution Numbers: 218073718 to 227260207
- Issue Price: Rs. 134/-
- ISIN: INE495B01038
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
- Trading members are informed of the new securities listing
- Lock-in period applies until March 9, 2026 for all issued shares
Important Dates
- Allotment Date: July 16, 2025
- Trading Commencement: August 28, 2025
- Lock-in Expiry: March 9, 2026
Impact Assessment
Minimal market impact expected as this is a routine listing of shares issued through warrant conversion. The lock-in period until March 2026 prevents immediate trading of these shares, limiting any potential dilution effect on existing shareholders.
Impact Justification
Routine listing of new equity shares through warrant conversion with minimal market impact